Chemesis International Inc. (CSE:CSI, OTC:CADMF)(FRA: CWAA) (the “Company” or “Chemesis”), announces the appointment of Mr. Deepak Anand to its Board of Directors. Mr. Anand brings over 15 years of leadership in the health, charitable, and private sectors, where he has amassed a wealth of experience in regard to business development, strategy and executive leadership.

Mr. Anand has served on the boards of many associations in Canada, the United States and Europe. Within the global cannabis sector, he has worked in conjunction with governmental officials, politicians, policy makers, health professional organizations, educators, investors, patients as well as producers. Mr. Anand holds a Master’s in Business Administration (MBA) from Vancouver Island University.


Currently, Mr. Anand serves on the boards of the Center for Medicinal Cannabis in the UK and he is also on the board of CFAMM (Canadians for Fair Access to Medical Marijuana) and the National Association of Cannabis Professionals. He was most recently appointed as Vice President for NORML Canada (National Organization for the Reform of Marijuana Laws).

The many prominent positions held by Mr. Anand in the cannabis industry include:

  • Vice President of Business Development and Government Relations at Cannabis Compliance Inc., Canada.
  • Vice President for Zenabis Global Inc., a Health Canada licensed producer under the ACMPR with facilities in British Columbia and New Brunswick, Canada.
  • Adjunct Professor at Kwantlen Polytechnic University (“KPU”). At KPU, Mr. Anand wrote, and taught Canada’s first and only Cannabis course titled ‘Cannabis Professional Series’ taught via an online module.
  • Executive Director for the Canadian National Medical Marijuana Association (CNMMA).

“I look forward to bringing my experience from the Canadian and Global Cannabis industry to provide strategic guidance to the team at Chemesis,” said Deepak Anand. “The Company has been able to assemble an incredible portfolio of assets and I look forward to adding a global strategy to the vision.”

“The addition of Mr. Anand brings a wealth of experience and relationships that we believe will build value and generate long term growth for Chemesis,” said CEO, Edgar Montero. “His current involvement in the cannabis industry and leadership will allow him to quickly acclimate, especially as Chemesis continues to establish its operations.”

On Behalf of The Board of Directors
Edgar Montero
CEO and Director

About Chemesis International Inc.

Chemesis International Inc. is a vertically integrated global leader in the cannabis industry, currently operating within California, Puerto Rico, and Colombia.

Chemesis is developing a strong foothold in key markets, from cultivation, to manufacturing, distribution and retail. Chemesis has facilities in both Puerto Rico and California, allowing for cost effective production and distribution of its products. In addition, Chemesis leverages exclusive brands and partnerships and uses the highest quality extraction methods to provide consumers with quality cannabis products.

Chemesis will add shareholder value by exploring opportunities in emerging markets while consistently delivering quality product to its consumers from seed to sale.

Investor Relations:
ir@chemesis.com
1 (604) 398-3378

Social Media:
Chemesis.facebook
Chemesis.twitter
Chemesis.instagram
DesertZen.instagram
CaliforniaSap.instagram
Jay&SB.instagram

Forward-Looking Information: This news release contains “forward-looking information” within the meaning of applicable securities laws relating to statements regarding the Company’s business, products and future of the Company’s business, its expansion plans, product offerings and plans for sales and marketing. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking information. Such forward-looking statements are subject to risks and uncertainties that may cause actual results, performance and developments to differ materially from those contemplated by these statements, including, among other things, the risks that the Company’s products and plans will vary from those stated in this news release and the Company may not be able to carry out its business plans as expected. Except as required by law, the Company expressly disclaims any obligation and does not intend to update any forward-looking statements or forward-looking information in this news release. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct and makes no reference to profitability based on sales reported. The statements in this news release are made as of the date of this release.

The CSE has not reviewed, approved or disapproved the content of this press release

Source: globenewswire.ca

American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.

Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.

Keep reading... Show less

An Emerging Markets Sponsored Commentary

Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.

Keep reading... Show less

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less